Daniel Gottlieb is a Managing Director at Broadview Ventures where he leads the MedTech practice. He has experience in the development and commercialization of cardiovascular disease treatments.

What Daniel can write

Writes checks ofNot reported
Comes in atSeed, Series ACan lead the round
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Career

  1. Guidant · marketing roles and member of Guidant Compass
  2. Abbott Vascular · marketing roles
  3. Proteon Therapeutics · Vice President of Corporate Development
  4. Broadview Ventures · Managing Director
    Now

Investments named in public bios

XII MedicalCardiosenseAlleviantCroíValveNyra MedicalCorFlowNido SurgicalPuzzle MedicalCardioMEMSNeovasc

Focus

cardiovascular diseasemedical devicesbiotechcorporate venture capitalMedTech

Education

University of Pennsylvania, BATuck School of Business at Dartmouth College, MBA

Also at Broadview Ventures

Partners like Daniel

At firms with a similar stage, sector and check size.

Alert me when Broadview Ventures is active

One email when Daniel's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Daniel Gottlieb?

Daniel Gottlieb is a Managing Director at Broadview Ventures where he leads the MedTech practice. He has experience in the development and commercialization of cardiovascular disease treatments.

How much does Daniel Gottlieb invest?

Broadview Ventures has not reported a check size. It invests at seed, series a.

How do I pitch Daniel Gottlieb?

A warm intro from a founder Broadview Ventures backed works best. A short LinkedIn note with one line on traction is the next best route.

What did Daniel Gottlieb do before Broadview Ventures?

marketing roles and member of Guidant Compass at Guidant; marketing roles at Abbott Vascular; Vice President of Corporate Development at Proteon Therapeutics.

Last updated 2026-10-15. Is this you? Ask for a correction.